DACH1 mutation frequency in endometrial cancer is associated with high tumor mutation burden.

by McKayla J Riggs, Nan Lin, Chi Wang, Dava W Piecoro, Rachel W Miller, Oliver A Hampton, Mahadev Rao, Frederick R Ueland, Jill M Kolesar
Published 2020-01-01

Utilizing Patient-Derived Epithelial Ovarian Cancer Tumor Organoids to Predict Carboplatin Resistance

by Justin W. Gorski, Zhuwei Zhang, J. Robert McCorkle, Jodi M. DeJohn, Chi Wang, Rachel W. Miller, Holly H. Gallion, Charles S. Dietrich, Frederick R. Ueland, Jill M. Kolesar
Published 2021-08-01

Symptoms Relevant to Surveillance for Ovarian Cancer

by Robert M. Ore, Lauren Baldwin, Dylan Woolum, Erika Elliott, Christiaan Wijers, Chieh-Yu Chen, Rachel W. Miller, Christopher P. DeSimone, Frederick R. Ueland, Richard J. Kryscio, John R. van Nagell, Edward J. Pavlik
Published 2017-03-01

Clinical Factors Associated with Longer Hospital Stay Following Ovarian Cancer Surgery

by Christopher G. Smith, Daniel L. Davenport, Justin Gorski, Anthony McDowell, Brian T. Burgess, Tricia I. Fredericks, Lauren A. Baldwin, Rachel W. Miller, Christopher P. DeSimone, Charles S. Dietrich, Holly H. Gallion, Edward J. Pavlik, John R. van Nagell, Frederick R. Ueland
Published 2019-07-01

Disease-Specific Survival of Type I and Type II Epithelial Ovarian Cancers—Stage Challenges Categorical Assignments of Indolence & Aggressiveness

by Edward J. Pavlik, Christopher Smith, Taylor S. Dennis, Elizabeth Harvey, Bin Huang, Quan Chen, Dava West Piecoro, Brian T. Burgess, Anthony McDowell, Justin Gorski, Lauren A. Baldwin, Rachel W. Miller, Christopher P. DeSimone, Charles Dietrich, Holly H. Gallion, Frederick R. Ueland, John R. van Nagell
Published 2020-01-01